Last reviewed · How we verify
K40a
At a glance
| Generic name | K40a |
|---|---|
| Also known as | K301a |
| Sponsor | Moberg Pharma AB |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Two Topical K40 Formulations in Adults With Seborrhoeic Dermatitis (SD) of the Scalp (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |